| Typicality: | 0.430 |
| Saliency: | 0.346 |
| with not prednisolone | 7 | other |
| with glybenclamide | 5 | other |
| significantly | 4 | degree |
| expression → be induced by → treatment | 11 |
| expression → be affected by → treatment | 5 |
| expression → be inhibited by → treatment | 5 |
| negative | neutral | positive |
| 0.240 | 0.707 | 0.053 |
| Raw frequency | 21 |
| Normalized frequency | 0.346 |
| Modifier score | 0.600 |
| Perplexity | 49.127 |